Perseus Proteomics Inc.
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
4882 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 目黒区駒場四丁目７番６号
- Website:
- https://www.ppmx.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Perseus Proteomics Inc. is a drug discovery biotechnology company founded in 2001 as a venture from the University of Tokyo. The company focuses on creating novel antibody-based therapeutics to treat cancer and other diseases, utilizing its proprietary and unique antibody technologies. Its business operations are structured around three core segments: Drug Discovery, which develops its pipeline of potential antibody drugs; Antibody Research Support Services for partner institutions; and the direct sale of antibody products and diagnostic reagents, such as ELISA kits. The company's mission is to contribute to global healthcare by developing innovative treatments for people suffering from diseases worldwide.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Perseus Proteomics Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 09:28 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 25.9 KB | |
| 2025-06-27 08:34 |
Registration Form
確認書
|
Japanese | 8.2 KB | |
| 2025-06-27 08:33 |
Regulatory News Service
訂正有価証券報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 1.5 MB | |
| 2025-06-27 08:33 |
Registration Form
確認書
|
Japanese | 8.2 KB | |
| 2025-06-27 08:32 |
Regulatory News Service
訂正有価証券報告書－第23期(2022/04/01－2023/03/31)
|
Japanese | 1.5 MB | |
| 2025-06-27 08:32 |
Regulatory News Service
内部統制報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 22.4 KB | |
| 2025-06-27 08:31 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-27 08:31 |
Annual Report
有価証券報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 2.6 MB | |
| 2025-05-21 08:31 |
Regulatory News Service
臨時報告書
|
Japanese | 20.2 KB | |
| 2024-11-14 07:34 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-11-14 07:34 |
Interim Report
半期報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 163.4 KB | |
| 2024-06-20 07:40 |
Regulatory News Service
臨時報告書
|
Japanese | 23.6 KB | |
| 2024-06-20 07:34 |
Regulatory News Service
内部統制報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 21.2 KB | |
| 2024-06-20 07:34 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-20 07:33 |
Annual Report
有価証券報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 2.8 MB |
Automate Your Workflow. Get a real-time feed of all Perseus Proteomics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Perseus Proteomics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
